Felix Baldauf-Lenschen
Founder and CEO
Altis Labs
AI endpoints that predict patient outcomes from clinical trial imaging
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Altis Labs is a Toronto-based company building AI endpoints for oncology clinical development. Its flagship model, IPRO, generates survival predictions and spatial imaging biomarkers from routinely acquired radiology CT scans so biopharma sponsors can assess treatment effect earlier than conventional imaging endpoints like ORR. The company trains models on a multimodal oncology database linking imaging, molecular, clinical, and outcomes data. In September 2026 Altis announced a US$25 million Series A co-led by OrbiMed and Qiming Venture Partners USA. Founded in 2019 by Felix Baldauf-Lenschen.
- Website
- altislabs.com
- Stage
- series-a
- Founded
- 2019
- Location
- Toronto, Ontario, Canada
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- IPRO — Imaging-based prognostication AI endpoint for oncology trials · Saas